No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
SGMT Sagimet Biosciences
- 4.060
- +0.010+0.25%
Close Jan 30 16:00 ET
- 4.100
- +0.040+0.99%
Post 16:26 ET
130.71MMarket Cap-3.48P/E (TTM)
4.190High3.970Low585.35KVolume4.110Open4.050Pre Close2.39MTurnover3.28%Turnover RatioLossP/E (Static)32.20MShares10.87052wk High0.77P/B72.40MFloat Cap2.39052wk Low--Dividend TTM17.83MShs Float20.710Historical High--Div YieldTTM5.43%Amplitude2.130Historical Low4.083Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
This Vital Farms Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Sagimet Biosciences Analyst Ratings
JonesTrading Initiates Sagimet Biosciences(SGMT.US) With Buy Rating, Announces Target Price $42
Analysts Offer Insights on Healthcare Companies: Sagimet Biosciences, Inc. Class A (SGMT) and Blueprint Medicines (BPMC)
Express News | Sagimet Biosciences Inc : Jonestrading Initiates Coverage With Buy Rating; Price Target $42
JMP Securities Maintains Sagimet Biosciences(SGMT.US) With Buy Rating, Maintains Target Price $31
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.